Skip to content
Search

Latest Stories

Pharmacists' expertise crucial in success of virus jabs but safety of staff and patients paramount: RPS

The Royal Pharmaceutical Society has reiterated that pharmacists have the expertise to play a crucial role in administering Covid-19 vaccinations.

"We need assurances from the NHS and governments that the programme will not disrupt our already stretched workforce but make way for greater collaboration between health professionals and minimise the impact on routine practice," RPS president Sandra Gidley said after news that the Medicines and Healthcare products Regulatory Agency (MHRA) approved the Pfizer/BioNTech Covid-19 vaccine for rollout in the UK from next week.


In a statement on pharmacists’ role in the programme, RPS recognises that any vaccination strategy must minimise disruption to routine practice across all sectors and ensure that patients can still access the medicines, services and health care they need, whilst utilising the expertise and leadership of pharmacists from all sectors of the NHS to deliver the Covid-19 vaccination.

It also highlights how pharmacists can help with strategic planning, oversight of vaccination distribution arrangements as well as operational roles in preparation for the vaccine programme rollout.

"The distribution and administration of the Covid-19 vaccination programme will require concerted action across the NHS," the professional body said.

The RPS statement also highlighted the importance of:

  • The role of pharmacists in providing information to the general public about the vaccine to maximise its uptake
  • Using the skills of pharmacists in all sectors as part of a networked approach.
  • Encouraging collaboration between health professionals
  • Undertaking vaccination training and access up to date information about the vaccines
  • Guaranteed supply of clinical consumables used for vaccinations

Gidley added: "Safety is absolutely our number one priority, both for patients and for those administrating the vaccine. Pharmacists and their teams have been caring for the public and exposing themselves to the virus all through the pandemic, so it’s only fair that they are protected with this vaccine and continue to receive all forms of protective equipment.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less